When COVID-19 first emerged, the U.S., under President Donald Trump, made an urgent bet on vaccines — and it paid off ...

Federal regulators are asking Novavax to complete an additional randomized clinical trial on its Covid-19 vaccine after ...

The CDC is considering recommending annual COVID-19 shots to those who are older or who have compromised immune function, ...

Under direction of Health Secretary Robert F. Kennedy Jr., the CDC is considering changes to its recommendations on vaccines ...

SARS-CoV-2 When COVID initially hit, there was a scramble within the vaccine community to cultivate an effective vaccine to help stop or lessen the detrimental effects of the virus. "In 2020 ...

Given the low effectiveness against infection ... Only 30 percent of nursing home residents received the latest coronavirus vaccine, and just 26 percent of seniors who were hospitalized for ...

Convidencia differs in many ways from the current COVID vaccines available, and the possibility of administering it via an inhaler allows those with needle phobias an alternative method of ...

At the peak of the COVID-19 pandemic, many vaccine skeptics turned to ivermectin, a medication proven to fight off parasitic ...

is weighing pulling the Covid-19 vaccine from the government ... Kennedy amplified doubts and conspiracy theories about the vaccine’s safety and effectiveness and launched several formal ...

A vaccine under development has demonstrated complete protection in mice against a deadly variant of the virus that causes bird flu. The work focuses on the H5N1 variant known as 2.3.4.4b, which has ...

Shira Doron, MD, MS, is an infectious diseases physician at Tufts Medical Center and the Chief Infection Control Officer for the Tufts Medicine health system. Monica Gandhi, MD, MPH, is an infectious ...

Novavax (NasdaqGS:NVAX) recently announced preliminary results from its SHIELD-Utah study, showcasing the Novavax COVID-19 vaccine's effectiveness and reduced side effects compared to a competitor's ...